Kestra Medical Technologies Ltd (KMTS) Price Prediction & ForecastKMTSKestra Medical Technologies Ltd

Alphio's KMTS stock price prediction model matches the current Kestra Medical Technologies Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.68 (+1.60%). The 1-week path is $28.50 (+4.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kestra Medical Technologies is a good buy right now due to its impressive revenue growth of 60% year-over-year, reaching $31 million in Q1 2027, and a current price of $26.98, which is below the analyst price target of $30. Additionally, the gross margin has improved significantly to 56.5%, indicating strong operational efficiency. The main risk is the net loss of $44.09 million reported for Q1 2027, which is a substantial increase from the previous year's loss.

Kestra Medical Technologies Ltd (KMTS) last closed at $27.24, losing -5.02%. These facts feed the 1-day and 1-week KMTS price prediction above.